Amid a volatile macroeconomic environment and heightened recessionary fears, medical stock Johnson and Johnson (JNJ), with a history of stable dividend payments, could be a wise choice for investors to safeguard themselves against market downturns. Let us delve deeper to find more.
Although persistent rate hikes have weighed heavily on the whole economy for quite some time, on the contrary, medical companies have fared well. Despite challenges such as high inflation, supply chain issues, and labor shortages, these companies face an inelastic demand for their products and services.
